|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
AU2927892A
(en)
|
1991-11-16 |
1993-06-15 |
Smithkline Beecham Biologicals (Sa) |
Hybrid protein between cs from plasmodium and hbsag
|
|
US5580773A
(en)
|
1992-06-17 |
1996-12-03 |
Korea Green Cross Corporation |
Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
|
|
JPH07291996A
(ja)
|
1994-03-01 |
1995-11-07 |
Yuu Honshiyo |
ヒトにおけるプログラムされた細胞死に関連したポリペプチド、それをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのポリペプチドまたはその抗体を含有する薬学的組成物
|
|
WO1997012048A1
(en)
|
1995-09-27 |
1997-04-03 |
Medical Research Council |
Recombinant viruses incorporating a protease cleavable protein
|
|
EP1054973A1
(en)
|
1998-02-11 |
2000-11-29 |
Maxygen, Inc. |
Antigen library immunization
|
|
PL354286A1
(en)
|
1999-08-23 |
2003-12-29 |
Dana-Farber Cancer Institutedana-Farber Cancer Institute |
Pd-1, a receptor for b7-4, and uses therefor
|
|
AU2002344190B2
(en)
|
2001-05-30 |
2007-10-18 |
Transgene S.A. |
Adenovirus protein IX, Its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
|
|
AU2003281200A1
(en)
|
2002-07-03 |
2004-01-23 |
Tasuku Honjo |
Immunopotentiating compositions
|
|
AU2003295470A1
(en)
|
2002-11-13 |
2004-06-03 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
|
|
CA2527636A1
(en)
*
|
2003-05-29 |
2005-01-06 |
United States Army Medical Research Institute For Infectious Diseases, A Research Laboratory Owned And Operated By The United States Government A |
Live attenuated viral vaccines for eastern equine encephalitis virus
|
|
CA2547511A1
(en)
|
2003-12-01 |
2005-07-28 |
Dow Global Technolgies Inc. |
Recombinant icosahedral virus like particle production in pseudomonads
|
|
EA016648B1
(ru)
|
2004-10-14 |
2012-06-29 |
Круселл Холланд Б.В. |
Применение дефектного по репликации рекомбинантного аденовируса, содержащего гетерологичную нуклеиновую кислоту, кодирующую антиген cs возбудителя малярии, и белкового антигена, содержащего белок cs или его фрагмент, для лечения или профилактики малярии
|
|
WO2006088229A1
(ja)
|
2005-02-16 |
2006-08-24 |
The Circle For The Promotion Of Science And Engineering |
改変されたウイルスカプシドタンパク質及びその使用
|
|
CA2611861C
(en)
|
2005-06-08 |
2017-11-28 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for the treatment of persistent infections
|
|
GB0513421D0
(en)
|
2005-06-30 |
2005-08-03 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
CU23586A1
(es)
|
2005-11-22 |
2010-10-30 |
Ct Ingenieria Genetica Biotech |
Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
|
|
US8216996B2
(en)
|
2006-03-03 |
2012-07-10 |
Ono Pharmaceutical Co., Ltd. |
Multimer of extracellular domain of cell surface functional molecule
|
|
US20100120092A1
(en)
|
2006-08-30 |
2010-05-13 |
Hepgenics Pty Ltd. |
Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same
|
|
AU2008338803B2
(en)
|
2007-11-26 |
2015-02-05 |
Glaxosmithkline Biologicals S.A. |
Methods of generating alphavirus particles
|
|
EP2370455B1
(en)
*
|
2008-11-26 |
2019-07-03 |
Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Virus like particle compositions and methods of use
|
|
PL2370099T3
(pl)
*
|
2008-12-09 |
2016-10-31 |
|
Zmodyfikowane białka F RSV i sposoby ich zastosowania
|
|
EP2477650B8
(en)
|
2009-09-18 |
2019-10-09 |
FRAUNHOFER USA Inc. |
Virus like particles comprising target proteins fused to plant viral coat proteins
|
|
WO2012006180A1
(en)
|
2010-06-29 |
2012-01-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv immunogens
|
|
WO2012023995A1
(en)
|
2010-08-18 |
2012-02-23 |
Takayuki Shiratsuchi |
Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes
|
|
US9487563B2
(en)
|
2011-01-31 |
2016-11-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Virus-like particles and methods of use
|
|
CN103561771B
(zh)
|
2011-03-17 |
2019-01-04 |
伯明翰大学 |
重新定向的免疫治疗
|
|
EP2720715B1
(en)
|
2011-06-17 |
2017-08-09 |
Bharat Biotech International Limited |
Vaccine composition comprising an inactivated chikungunya virus strain
|
|
CN102321639B
(zh)
|
2011-09-08 |
2013-06-26 |
中国疾病预防控制中心病毒病预防控制所 |
基孔肯雅病毒病毒样颗粒的制备方法和应用
|
|
SG11201401733VA
(en)
|
2011-10-25 |
2014-09-26 |
Florida Gulf Coast University |
Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
|
|
KR102181258B1
(ko)
*
|
2012-02-16 |
2020-11-20 |
브이엘피 테라퓨틱스 엘엘씨 |
바이러스 유사 입자 조성물
|
|
US9821050B2
(en)
|
2012-04-02 |
2017-11-21 |
The University Of North Carolina At Chapel Hill |
Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
|
|
HRP20181102T1
(hr)
|
2012-05-16 |
2018-09-07 |
Immune Design Corp |
Cjepiva za hsv-2
|
|
SG10201709917VA
(en)
|
2013-06-03 |
2017-12-28 |
Vlp Therapeutics Llc |
Malaria vaccine
|
|
TWI676636B
(zh)
|
2013-07-12 |
2019-11-11 |
Ｖｌｐ醫療股份有限公司 |
包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子
|
|
US10060924B2
(en)
|
2014-03-18 |
2018-08-28 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Distinguishing flavivirus infection using a recombinant mutant envelope protein
|
|
US9969986B2
(en)
|
2014-08-08 |
2018-05-15 |
Vlp Therapeutics, Llc |
Virus like particle comprising modified envelope protein E3
|
|
US10385101B2
(en)
|
2014-08-08 |
2019-08-20 |
Vlp Therapeutics, Llc |
Virus like particle comprising modified envelope protein E3
|
|
US9363353B1
(en)
|
2014-12-04 |
2016-06-07 |
Hon Man Ashley Chik |
Mobile phone docks with multiple circulating phone connectors
|
|
US11191727B2
(en)
*
|
2014-12-31 |
2021-12-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Multivalent nanoparticle-based vaccines
|
|
JPWO2016199936A1
(ja)
|
2015-06-12 |
2018-04-05 |
国立大学法人三重大学 |
ヒトパラインフルエンザ２型ウイルスベクター及びワクチン
|
|
US10799575B2
(en)
|
2015-06-25 |
2020-10-13 |
Technovax, Inc. |
Flavivirus and alphavirus virus-like particles (VLPS)
|
|
EP3322441A4
(en)
|
2015-07-16 |
2018-12-19 |
Bharat Biotech International Limited |
Vaccine compositions
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
CN106085974B
(zh)
|
2016-06-07 |
2019-08-09 |
博奥生物集团有限公司 |
一种寨卡病毒假病毒颗粒及其制备方法
|